Jim Cramer's Best Blogs (RealMoney.com $)
Catch up on Jim Cramer's thinking on the hottest topics of the past week.
08:54AM 11/28/09
Establishing a Healthy New Holding (ETF Action - Alerts $)
Initiating a play on U.S.-based drugmakers, as this group is currently showing a great deal of promise.
09:16AM 11/27/09
INSIDE WASHINGTON: Stream Of WH Health Care Visits
INSIDE WASHINGTON: Lobbyists, health care heavyweights visited White House early and often
10:48AM 11/26/09
Integrity Underpins Reputation: The Innovators
Integrity is that dependability at the heart of relationships and corporate trust.
09:00AM 11/26/09
Black Friday Short-Squeeze Opportunities
These heavily shorted stocks could surge higher on any positive catalyst.
01:44PM 11/25/09
INSIDE WASHINGTON: Stream Of WH Health Care Visits
INSIDE WASHINGTON: Lobbyists, health care heavyweights visited White House early and often
01:12PM 11/25/09
Healthcare Stocks: Safe and Speculative
NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio.
12:56PM 11/23/09
Sanofi Has Lots of Upside Catalysts (RealMoney.com $)
Looks like the patent worries aren't so dire after all.
08:12AM 11/23/09
Tracking the Hedgies (RealMoney Silver $)
Here is a summary of Goldman Sachs' Hedge Fund Trend Monitor this week.
08:08AM 11/23/09
FDA OKs Abilify For Autism-linked Irritability
FDA OKs Bristol-Meyers' Abilify to treat irritability linked to autism in children, teens
07:27PM 11/20/09
Pfizer's Geodon Gets Expanded FDA Approval
Pfizer's bipolar disorder drug Geodon receives expanded FDA approval
02:15PM 11/20/09
Pfizer Gets FDA Approval For Intravenous Revatio
Pfizer receives FDA approval for intravenous version of high blood pressure drug Revatio
11:16AM 11/20/09
'Fast Money' Recap: Playing Defense
The trading panel discussed moves for a market that is shifting to the downside.
07:46PM 11/19/09
FDA Panel Backs Safety, Benefits Of Spiriva
FDA panel backs stronger benefit claims and safety profile for inhaler drug Spiriva
02:38PM 11/19/09
Moody's Gives Negative View On Pharma Credit
Moody's: credit ratings for drugmakers could be hurt as industry copes with expiring patents
01:15PM 11/19/09



Connect with TheStreet